Dr. Reddy’s Laboratories RDY has announced a definitive agreement with Haleon plc HLN to acquire its global portfolio of consumer healthcare brands in the Nicotine Replacement Therapy (NRT) category, ...
Portfolio to be acquired consists of global NRT brand Nicotinell and its local market-leading brand names Nicabate, Habitrol and Thrive in markets outside of the United States Acquisition seen as ...
Dr. Reddy's Laboratories (NYSE:RDY) on Wednesday announced a deal to acquire a women's health and dietary supplements portfolio of brands from Amyris (OTC:AMRSQ) as part of the latter's Chapter 11 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback